FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Suetonia Palmer

Research Profile

Concepts & Ideas

Devices

Vascular Access Devices

Disorders

Chemicals & Drugs

Procedures

Renal Dialysis

Co-author Network

Publications

TOP 3
Azrina M Ralib; Geoffrey M Shaw; David A Goodkin; Tamas Major; Suetonia C Palmer; John W Pickering; Zoltán H Endre
High-dose intravenous epoetin does not increase blood pressure in critically ill patients with acute kidney injury.
Suetonia C Palmer; Fabio Pellegrini; Marcello Tonelli; Adrian Covic; Jonathan C Craig; Piergiorgio Messa; Ionut Nistor; G F M Strippoli
Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials.
Lynley K Lewis; Suetonia C Palmer; Sara D Raudsepp; Richard W Troughton; Timothy G Yandle; Christopher M Frampton; A Mark Richards
Comparison of immunoassays for NTproBNP conducted on three analysis systems: Milliplex, Elecsys and RIA.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Suetonia Palmer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Azrina M Ralib; Geoffrey M Shaw; David A Goodkin; Tamas Major; Suetonia C Palmer; John W Pickering; Zoltán H Endre
High-dose intravenous epoetin does not increase blood pressure in critically ill patients with acute kidney injury.
Clinical nephrology 2013;79(5):370-9.
2013: Suetonia C Palmer; Fabio Pellegrini; Marcello Tonelli; Adrian Covic; Jonathan C Craig; Piergiorgio Messa; Ionut Nistor; G F M Strippoli
Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials.
PLoS medicine 2013;10(4):e1001436.
2013: Lynley K Lewis; Suetonia C Palmer; Sara D Raudsepp; Richard W Troughton; Timothy G Yandle; Christopher M Frampton; A Mark Richards
Comparison of immunoassays for NTproBNP conducted on three analysis systems: Milliplex, Elecsys and RIA.
Clinical biochemistry 2013;46(4-5):388-90.
2013: Pietro Ravani; Giovanni F M Strippoli; Davina J Tai; Chandra Thomas; Marcello Tonelli; Jennifer M MacRae; Braden Manns; Matthew J Oliver; Suetonia C Palmer; Neesh I Pannu; Robert R Quinn; Jonathan C Craig; Brenda R Hemmelgarn; Matthew T James
Associations between hemodialysis access type and clinical outcomes: a systematic review.
Journal of the American Society of Nephrology : JASN 2013;24(3):465-73.
2013: Suetonia C Palmer; Fabio Pellegrini; Vlado Perkovic; Mona Razavian; Jonathan C Craig; Lucia Di Micco; Meg J Jardine; Angela C Webster; Sophia Zoungas; G F M Strippoli
Antiplatelet agents for chronic kidney disease.
Cochrane database of systematic reviews (Online) 2013;4():CD008834.
2013: Suetonia C Palmer; Fabio Pellegrini; Vlado Perkovic; Mona Razavian; Jonathan C Craig; Lucia Di Micco; Meg J Jardine; Angela C Webster; Sophia Zoungas; G F M Strippoli
Antiplatelet agents for chronic kidney disease.
Cochrane database of systematic reviews (Online) 2013;2():CD008834.
2013: Suetonia C Palmer; Fabio Pellegrini; Vlado Perkovic; Pietro Ravani; Mona Razavian; Jonathan C Craig; Lucia Di Micco; Giusi Graziano; Meg Jardine; Antonio Nicolucci; Gianni Tognoni; Angela Webster; G F M Strippoli
Antiplatelet therapy to prevent hemodialysis vascular access failure: systematic review and meta-analysis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2013;61(1):112-22.
2012: Mariacristina Vecchio; Marcello Tonelli; David W Johnson; Suetonia C Palmer; Giovanni F M Strippoli
Depression and sexual dysfunction in chronic kidney disease: a narrative review of the evidence in areas of significant unmet need.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012;27(9):3420-8.
2012: Suetonia C Palmer; Fabio Pellegrini; Jonathan C Craig; Sankar D Navaneethan; Marcello Tonelli; Giovanni F M Strippoli
Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis.
Annals of internal medicine 2012;157(4):263-75.
2012: Chris J Pemberton; Torsten Kleffmann; Suetonia C Palmer; Peter Ruygrok; Maithri Siriwardena; Tim G Yandle; A Mark Richards
First identification of circulating prepro-A-type natriuretic peptide (preproANP) signal peptide fragments in humans: initial assessment as cardiovascular biomarkers.
Clinical chemistry 2012;58(4):757-67.
2012: Suetonia C Palmer; Fabio Pellegrini; Vlado Perkovic; Mona Razavian; Massimiliano Copetti; Jonathan C Craig; Lucia Di Micco; Giusi Graziano; Meg Jardine; Antonio Nicolucci; Gianni Tognoni; Angela Webster; Sophia Zoungas; Giovanni F M Strippoli
Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-analysis.
Annals of internal medicine 2012;156(6):445-59.
2012: Suetonia C Palmer; Kannaiyan S Rabindranath; Paul J Roderick; Jonathan C Craig; Francesco Locatelli; G F M Strippoli
High-flux versus low-flux membranes for end-stage kidney disease.
Cochrane database of systematic reviews (Online) 2012;9():CD005016.
2011: Suetonia C Palmer; Giovanni F M Strippoli
Cardiovascular diseases: Lipid-lowering in CKD--at the SHARP end of the evidence?
Nature reviews. Nephrology 2011;7(11):609-11.
2011: Amjad K Hamid; John G Lainchbury; Iain C Melton; Paul G Bridgman; Ian G Crozier; Chris M Frampton; Suetonia C Palmer; A Mark Richards; M Gary Nicholls
Prediction of cardiac rhythm 1 year following cardioversion for atrial fibrillation.
The New Zealand medical journal 2011;124(1343):48-56.
2011: Suetonia C Palmer; Michela Sciancalepore; G F M Strippoli
Trial quality in nephrology: how are we measuring up?
American journal of kidney diseases : the official journal of the National Kidney Foundation 2011;58(3):335-7.
2011: Suetonia C Palmer; Andrew Hayen; Petra Macaskill; Fabio Pellegrini; Jonathan C Craig; Grahame J Elder; G F M Strippoli
Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis.
JAMA : the journal of the American Medical Association 2011;305(11):1119-27.
2011: Sankar D Navaneethan; Suetonia C Palmer; Mariacristina Vecchio; Jonathan C Craig; Grahame J Elder; G F M Strippoli
Phosphate binders for preventing and treating bone disease in chronic kidney disease patients.
Cochrane database of systematic reviews (Online) 2011;(2):CD006023.
2010: Sankar D Navaneethan; Suetonia C Palmer; Alicia Smith; David W Johnson; G F M Strippoli
How to design a randomized controlled trial.
Nephrology (Carlton, Vic.) 2010;15(8):732-9.
2010: Suetonia C Palmer; G F M Strippoli
How to read critically a prognostic cohort study.
Nephrology (Carlton, Vic.) 2010;15(7):676-82.
2010: Suetonia C Palmer; Sankar D Navaneethan; Jonathan C Craig; David W Johnson; Marcello Tonelli; Amit X Garg; Fabio Pellegrini; Pietro Ravani; Meg Jardine; Vlado Perkovic; Giusi Graziano; Richard McGee; Antonio Nicolucci; Gianni Tognoni; G F M Strippoli
Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease.
Annals of internal medicine 2010;153(1):23-33.
2010: Katrina L Ellis; Anna P Pilbrow; Chris M Frampton; Rob N Doughty; Gillian Whalley; Chris J Ellis; Barry Palmer; Lorraine Skelton; Tim G Yandle; Suetonia C Palmer; Richard W Troughton; A Mark Richards; Vicky A Cameron
A common variant at chromosome 9P21.3 is associated with age of onset of coronary disease but not subsequent mortality.
Circulation. Cardiovascular genetics 2010;3(3):286-93.
2010: Suetonia C Palmer; Sankar D Navaneethan; G F M Strippoli
How to read a nephrology systematic review.
Nephrology (Carlton, Vic.) 2010;15(2):158-64.
2009: Yen-Hsing Chen; Timothy G Yandle; A Mark Richards; Suetonia C Palmer
Urotensin II immunoreactivity in the human circulation: evidence for widespread tissue release.
Clinical chemistry 2009;55(11):2040-8.
2009: Sankar D Navaneethan; Suetonia C Palmer; Jonathan C Craig; Grahame J Elder; G F M Strippoli
Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2009;54(4):619-37.
2009: Suetonia C Palmer; Timothy C R Prickett; Eric A Espiner; Timothy G Yandle; A Mark Richards
Regional release and clearance of C-type natriuretic peptides in the human circulation and relation to cardiac function.
Hypertension 2009;54(3):612-8.
2009: Suetonia C Palmer; Timothy G Yandle; M Gary Nicholls; Christopher M Frampton; A Mark Richards
Regional clearance of amino-terminal pro-brain natriuretic peptide from human plasma.
European journal of heart failure 2009;11(9):832-9.
2009: Sankar D Navaneethan; Suetonia C Palmer; Martin J Schreiber; G F M Strippoli
Weighing the evidence for treatment of chronic kidney disease mineral and bone disorder.
Nephrology (Carlton, Vic.) 2009;14(4):363-6.
2009: Suetonia C Palmer; Timothy G Yandle; Christopher M Frampton; Richard W Troughton; M Gary Nicholls; A Mark Richards
Renal and cardiac function for long-term (10 year) risk stratification after myocardial infarction.
European heart journal 2009;30(12):1486-94.
2009: Suetonia C Palmer; Zoltan H Endre; A Mark Richards; Timothy G Yandle
Characterization of NT-proBNP in human urine.
Clinical chemistry 2009;55(6):1126-34.
2009: Suetonia C Palmer; Jonathan C Craig; G F M Strippoli
Taking aim at targets.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(5):1358-61.
2009: Suetonia C Palmer; A Mark Richards
Does renal clearance differ between the B-type natriuretic peptides (BNP versus NT-proBNP)?
Journal of the American College of Cardiology 2009;53(10):891-2.
2009: Suetonia C Palmer; David O McGregor; Jonathan C Craig; Grahame Elder; Petra Macaskill; G F M Strippoli
Vitamin D compounds for people with chronic kidney disease not requiring dialysis.
Cochrane database of systematic reviews (Online) 2009;(4):CD008175.
2009: Suetonia C Palmer; David O McGregor; Jonathan C Craig; Grahame Elder; Petra Macaskill; G F M Strippoli
Vitamin D compounds for people with chronic kidney disease requiring dialysis.
Cochrane database of systematic reviews (Online) 2009;(4):CD005633.
2007: Suetonia C Palmer; David O McGregor; Petra Macaskill; Jonathan C Craig; Grahame J Elder; G F M Strippoli
Meta-analysis: vitamin D compounds in chronic kidney disease.
Annals of internal medicine 2007;147(12):840-53.
2007: Suetonia C Palmer; Jonathan C Craig; G F M Strippoli
Sevelamer: a promising but unproven drug.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(10):2742-5.
2007: Suetonia C Palmer; David O McGregor; G F M Strippoli
Interventions for preventing bone disease in kidney transplant recipients.
Cochrane database of systematic reviews (Online) 2007;(3):CD005015.
2006: G F M Strippoli; Allison Tong; Suetonia C Palmer; Grahame Elder; Jonathan C Craig
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients.
Cochrane database of systematic reviews (Online) 2006;(4):CD006254.
2005: Suetonia C Palmer; G F M Strippoli; David O McGregor
Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;45(4):638-49.